Visit Flagship at the SB-IO Summit
January 17-19, 2023
Attending the inaugural SB-IO Summit? Stop by our booth to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program.
- AI-powered digital pathology solutions
- Immuno-oncology biomarker development and validation
- Spatial biology and molecular diagnostics analysis
- Immunotherapy clinical trial support
- CDx development
- Regulatory guidance
Tom Turi, Ph.D.
Chief Scientific Officer at
Flagship Biosciences
presents
Spatial Biology to Improve Clinical Trial Outcomes
Wednesday, January 18 at 11:15 am PST
- Increasing accuracy and yield of existing
biomarker assays - Investigating spatial and image analysis solutions
for patient selection - Expanding the use of spatial imaging applications
beyond oncology
The Digital Pathology Advantage
- Improve ROI, accelerate trials, and minimize budget impacts
- Minimize recruitment costs and other clinical trial expenses
- Discover cost benefits of Flagship’s image analysis platform
Driving Your Biomarker Strategy: Facts by numbers
- View our resume and history to learn why Flagship is the premier partner for your study
- See the full list of spatial biology services that empower confident clinical decision making
- See the benefits with a fully integrated team of scientists and pathologists
Interested in partnering with us?
Validated Assays for Spatial Biology
- View our validated IHC assays
- See our IHC/CISH optimized assays
- Learn our multiplex and custom panel options
Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications
- Expertise in novel biomarker and tissue analyses
- Regulatory strategy and support
- Consult with scientific experts
